Zynex Net Profit Margin 2010-2025 | ZYXI
Zynex net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Zynex Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.17B | $-0.01B | -4.62% |
| 2024-12-31 | $0.19B | $0.00B | 1.04% |
| 2024-09-30 | $0.19B | $0.00B | 2.06% |
| 2024-06-30 | $0.19B | $0.01B | 3.09% |
| 2024-03-31 | $0.19B | $0.01B | 4.23% |
| 2023-12-31 | $0.18B | $0.01B | 5.43% |
| 2023-09-30 | $0.19B | $0.02B | 8.60% |
| 2023-06-30 | $0.18B | $0.02B | 9.55% |
| 2023-03-31 | $0.17B | $0.02B | 10.00% |
| 2022-12-31 | $0.16B | $0.02B | 10.06% |
| 2022-09-30 | $0.15B | $0.02B | 12.00% |
| 2022-06-30 | $0.14B | $0.02B | 13.29% |
| 2022-03-31 | $0.14B | $0.02B | 13.87% |
| 2021-12-31 | $0.13B | $0.02B | 13.08% |
| 2021-09-30 | $0.12B | $0.01B | 8.62% |
| 2021-06-30 | $0.10B | $0.01B | 4.95% |
| 2021-03-31 | $0.09B | $0.01B | 5.62% |
| 2020-12-31 | $0.08B | $0.01B | 11.25% |
| 2020-09-30 | $0.07B | $0.01B | 14.71% |
| 2020-06-30 | $0.06B | $0.01B | 18.33% |
| 2020-03-31 | $0.05B | $0.01B | 19.61% |
| 2019-12-31 | $0.05B | $0.01B | 20.00% |
| 2019-09-30 | $0.04B | $0.01B | 22.50% |
| 2019-06-30 | $0.04B | $0.01B | 27.78% |
| 2019-03-31 | $0.03B | $0.01B | 29.41% |
| 2018-12-31 | $0.03B | $0.01B | 31.25% |
| 2018-09-30 | $0.03B | $0.01B | 32.26% |
| 2018-06-30 | $0.03B | $0.01B | 30.00% |
| 2018-03-31 | $0.03B | $0.01B | 33.33% |
| 2017-12-31 | $0.02B | $0.01B | 30.43% |
| 2017-09-30 | $0.02B | $0.00B | 22.22% |
| 2017-06-30 | $0.02B | $0.00B | 20.00% |
| 2017-03-31 | $0.01B | $0.00B | 7.69% |
| 2016-12-31 | $0.01B | $0.00B | 7.69% |
| 2016-09-30 | $0.01B | 0 | 0.00% |
| 2016-06-30 | $0.01B | $0.00B | -8.33% |
| 2016-03-31 | $0.01B | $0.00B | -8.33% |
| 2015-12-31 | $0.01B | $0.00B | -16.67% |
| 2015-09-30 | $0.01B | 0 | 0.00% |
| 2015-06-30 | $0.01B | 0 | 0.00% |
| 2015-03-31 | $0.01B | $-0.01B | -60.00% |
| 2014-12-31 | $0.01B | $-0.01B | -60.00% |
| 2014-09-30 | $0.01B | $-0.01B | -109.09% |
| 2014-06-30 | $0.01B | $-0.01B | -108.33% |
| 2014-03-31 | $0.02B | $-0.01B | -56.25% |
| 2013-12-31 | $0.02B | $-0.01B | -38.10% |
| 2013-09-30 | $0.03B | $0.00B | -10.34% |
| 2013-06-30 | $0.03B | $0.00B | -5.88% |
| 2013-03-31 | $0.04B | 0 | 0.00% |
| 2012-12-31 | $0.04B | 0 | 0.00% |
| 2012-09-30 | $0.04B | $0.00B | 2.56% |
| 2012-06-30 | $0.04B | $0.00B | 5.26% |
| 2012-03-31 | $0.04B | $0.00B | 5.56% |
| 2011-12-31 | $0.03B | $0.00B | 5.88% |
| 2011-09-30 | $0.03B | $0.00B | 3.23% |
| 2011-06-30 | $0.03B | 0 | 0.00% |
| 2011-03-31 | $0.03B | 0 | 0.00% |
| 2010-12-31 | $0.03B | 0 | 0.00% |
| 2010-09-30 | $0.02B | 0 | 0.00% |
| 2010-06-30 | $0.02B | 0 | 0.00% |
| 2010-03-31 | $0.02B | $0.00B | 5.26% |
| 2009-12-31 | $0.02B | $0.00B | 11.11% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.080B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.070B | 28.51 |
| Boston Scientific (BSX) | United States | $155.016B | 38.81 |
| Stryker (SYK) | United States | $151.431B | 31.66 |
| EssilorLuxottica (ESLOY) | France | $128.578B | 0.00 |
| Medtronic (MDT) | Ireland | $113.826B | 16.14 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.396B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.515B | 26.54 |
| ResMed (RMD) | United States | $37.575B | 28.22 |
| GE HealthCare Technologies (GEHC) | United States | $34.776B | 16.51 |
| Agilent Technologies (A) | United States | $34.216B | 22.31 |
| Terumo (TRUMY) | Japan | $26.620B | 34.58 |
| Koninklijke Philips (PHG) | Netherlands | $23.303B | 16.35 |
| Insulet (PODD) | United States | $21.112B | 82.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.610B | 11.95 |
| Baxter (BAX) | United States | $16.026B | 11.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.402B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.748B | 23.48 |
| Lantheus Holdings (LNTH) | United States | $5.495B | 13.86 |
| Prestige Consumer Healthcare (PBH) | United States | $3.969B | 17.73 |
| Perrigo (PRGO) | Ireland | $3.771B | 9.56 |
| Haemonetics (HAE) | United States | $3.667B | 16.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.393B | 28.20 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| QuidelOrtho (QDEL) | United States | $2.015B | 13.86 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 42.27 |
| AtriCure (ATRC) | United States | $1.594B | 0.00 |
| Acuren (TIC) | United States | $1.327B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.269B | 12.88 |
| Green Thumb Industries (GTBIF) | United States | $1.158B | 26.05 |
| Neogen (NEOG) | United States | $1.103B | 14.11 |
| Phibro Animal Health (PAHC) | United States | $1.079B | 13.79 |
| BioLife Solutions (BLFS) | United States | $1.029B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 9.45 |
| Kestra Medical Technologies (KMTS) | United States | $0.813B | 0.00 |
| Owens & Minor (OMI) | United States | $0.728B | 6.04 |
| CeriBell (CBLL) | United States | $0.671B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.487B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.443B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Surmodics (SRDX) | United States | $0.419B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.353B | 12.98 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.33 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| ZimVie (ZIMV) | United States | $0.274B | 12.46 |
| Cresco Labs (CRLBF) | United States | $0.258B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 64.88 |
| Aurora Cannabis (ACB) | Canada | $0.242B | 71.67 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.208B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.190B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Omeros (OMER) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.50 |
| TerrAscend (TSNDF) | Canada | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.081B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.75 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |